Active	Status	Sponsor type	Region	Phase	Filter
2 Active 13 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
GSK692342 / GSK, Bill & Melinda Gates Foundation
NCT06062238: Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults	Recruiting	3	20000	RoW	M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo	Bill & Melinda Gates Medical Research Institute, Wellcome Trust, Bill and Melinda Gates Foundation	Tuberculosis	04/28	04/28
MESA-TB, NCT04556981: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV	Completed	2	402	RoW	M72/AS01E Mycobacterium tuberculosis vaccine, Placebo	Bill & Melinda Gates Medical Research Institute, Wellcome Trust	Human Immunodeficiency Virus	08/22	08/22